Exploring the Mechanism of Lingzhu San in Treating Febrile Seizures by Using Network Pharmacology.
Lingzhu San
Network pharmacology
circulatory
dysfunctions
febrile seizures
molecular mechanisms
respiratory dysfunctions
Journal
Combinatorial chemistry & high throughput screening
ISSN: 1875-5402
Titre abrégé: Comb Chem High Throughput Screen
Pays: United Arab Emirates
ID NLM: 9810948
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
06
2020
revised:
25
07
2020
accepted:
06
08
2020
pubmed:
4
9
2020
medline:
23
3
2022
entrez:
4
9
2020
Statut:
ppublish
Résumé
Lingzhu San (LZS) is a traditional Chinese medicine (TCM) prescription that can be effective in treating febrile seizures (FS) and there are few research works conducted on its mechanisms. In order to better guide the clinical use of LZS, we used the research ideas and methods of network pharmacology to find the potential core compounds, targets and pathways of LZS in the complex TCM system for the treatment of FS, and predict the mechanism. Databases such as BATMAN, TCMSP, TCMID, and SWISS TARGET are used to mine the active compounds and targets of LZS, and the target information of FS is obtained through GENECARDS and OMIM. Using Venny2.1.0 and Cytoscape software, the potential core compounds and targets of FS were obtained. The R language and ClusterProfiler software package are adopted to enrich and analyze the KEGG and GO pathways of the core targets and the biological processes and potential mechanisms of the core targets are also revealed. 187 active compounds and 2113 target proteins of LZS were collected. And 38 potential core compounds, 35 core targets and 775 metabolic and functional pathways were screened, which were involved in mediating FS. Finally, the role of the core compounds, targets and pivotal pathways of LZS in regulating FS in the pathogenesis and the therapeutic mechanism of FS were discussed and clarified. In this paper, the multi-compounds, multi-targets and multi-pathways mechanism of LZS in the treatment of FS were preliminarily screened through the analysis of network pharmacology data, which are consistent with the principle of multi-compounds' compatibility with TCM prescriptions and a unified treatment of diseases from multiple aspects, and it provides a new way for TCM to treat complex diseases caused by multiple factors.
Identifiants
pubmed: 32881664
pii: CCHTS-EPUB-109631
doi: 10.2174/1386207323666200902144348
doi:
Substances chimiques
Drugs, Chinese Herbal
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1168-1182Subventions
Organisme : Shaanxi Provincial Traditional Chinese Medicine administration
ID : 2017001
Organisme : Chinese Medicine Pharmaceutical Key Discipline of Shaanxi province
ID : 303061107
Organisme : Shaanxi University of Chinese Medicine
ID : 2019-YL11
Organisme : Key Laboratory of Modern Chinese Medicine Preparation
ID : 2017003
Organisme : National key Research and Development Plan
ID : 2018YFC1706904
Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.